Skip NavigationSkip to Content

Corneal and conjunctival abnormalities in a cohort of survivors from the Western African Ebola virus disease outbreak

  1. Author:
    Fashina, Tolulope
    Nguyen, Nam V
    Huang, Ye
    Randleman, Casey
    Hartley, Caleb D
    Mattia, John G
    Vandy, Matthew J
    Harrison-Williams, Lloyd C
    Mustapha, Jalikatu
    Mwanza, Jean-Claude
    Hayek, Brent R
    Crozier,Ian
    Shantha, Jessica G
    Yeh, Steven
  2. Author Address

    Truhlsen Eye Institute, Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska, USA., College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Illinois Eye and Ear Infirmary, University of Illinois College of Medicine, Chicago, Illinois, USA., Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., National Eye Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone., Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina, USA., North Georgia Eye Associates, Gainesville, Georgia, USA., Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Francis I. Proctor Foundation for Ophthalmic Research, University of California San Francisco, San Francisco, California, USA., Emory Eye Center, Department of Ophthalmology, Emory University, Atlanta, Georgia, USA.,
    1. Year: 2024
    2. Date: Dec 11
    3. Epub Date: 2024 10 16
  1. Journal: AJO International
    1. 1
    2. 4
  2. Type of Article: Article
  1. Abstract:

    To characterize corneal and conjunctival abnormalities (CCAs) and their impact on visual acuity in a cohort of survivors from the Western African Ebola virus disease (EVD) outbreak. A post hoc analysis of 121 patients, who had previously undergone screening for the Ebola Virus Persistence in Ocular Tissues and Fluids study, was performed. Patients underwent a comprehensive ophthalmic exam at the Lowell and Ruth Gess Eye Hospital in Freetown, Sierra Leone. Demographic (including age, sex, and the number of days spent in the Ebola treatment unit and examination (such as visual acuity, and ocular complications) data were collected and used for the analysis. Visual acuity was either uncorrected or corrected with spectacles. Descriptive and inferential statistical analyses were performed, and a p-value < 0.05 was considered statistically significant. A total of 242 eyes (121 patients) were included in this study. The mean age was 31.5 ± 16.1 years, and 70 % were female. Of 242 eyes, 28 (11.5 %) eyes of 15 patients (12.4 %) presented with at least one or more corneal or conjunctival abnormalities. Within eyes that demonstrated CCAs, the findings included dry eye (28.6 % of eyes), band keratopathy (25 % of eyes), and corneal scar (21.4 % of eyes). Corneal edema was found in 14.3 % of eyes, while pterygium and epithelial bullae were each found in 7.1 % of affected eyes. Patients without CCAs had better visual acuity compared to patients with CCAs although the difference was not statistically significant (0.82 ± 1.17 vs 1.01 ± 1.29, p = 0.4). A subset of patients with CCAs also reported ocular symptoms including eye pain, light sensitivity, excessive tearing, and blurry vision. In this post hoc analysis, we observed CCAs in 12 % of EVD survivors. These findings highlight the potential for corneal and conjunctival sequelae during EVD survivorship and the need for ongoing ophthalmic care for this vulnerable population.

    See More

External Sources

  1. DOI: 10.1016/j.ajoint.2024.100075
  2. PMID: 39687308
  3. PMCID: PMC11647578
  4. PII : 100075

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel